Ll

Gilead's Stock Jumps 5% after Setting Patent Case Related to HIV Therapies

Shares of Gilead Sciences Inc. were up 5.2% in premarket trading on Monday after the company said in
Gilead's Stock Jumps 5% after Setting Patent Case Related to HIV Therapies

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment2

  • Top
  • Latest